In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

Hideki Ebihara, Steven Theriault, Gabriele Neumann, Judie B. Alimonti, Joan B. Geisbert, Lisa E. Hensley, Allison Groseth, Steven M. Jones, Thomas Geisbert, Yoshihiro Kawaoka, Heinz Feldmann

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinant viruses expressing enhanced green fluorescent protein (eGFP) from additional transcription units inserted at different positions in the virus genome. These viruses showed in vitro phenotypes similar to that of wild-type ZEBOV (wt-ZEBOV) and were stable over multiple passages. Infection with one of the viruses expressing eGFP produced only mild disease in rhesus macaques, demonstrating a marked attenuation in this animal model. However, in mice lacking signal transducer and activator of transcription 1, both viruses expressing eGFP caused lethal cases of disease that were moderately attenuated, compared with that caused by wt-ZEBOV. In mice, viral replication could be easily tracked by the detection of eGFP-positive cells in tissues, by use of flow cytometry. These findings demonstrate that the incorporation of a foreign gene will attenuate ZEBOV in vivo but that these viruses still have potential for in vitro and in vivo research applications.

Original languageEnglish (US)
JournalJournal of Infectious Diseases
Volume196
Issue numberSUPPL. 2
DOIs
StatePublished - Nov 15 2007
Externally publishedYes

Fingerprint

Ebolavirus
Viruses
Democratic Republic of the Congo
STAT1 Transcription Factor
Infection
Macaca mulatta
enhanced green fluorescent protein
In Vitro Techniques
Flow Cytometry
Animal Models
Genome
Phenotype
Research
Genes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Ebihara, H., Theriault, S., Neumann, G., Alimonti, J. B., Geisbert, J. B., Hensley, L. E., ... Feldmann, H. (2007). In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. Journal of Infectious Diseases, 196(SUPPL. 2). https://doi.org/10.1086/520590

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. / Ebihara, Hideki; Theriault, Steven; Neumann, Gabriele; Alimonti, Judie B.; Geisbert, Joan B.; Hensley, Lisa E.; Groseth, Allison; Jones, Steven M.; Geisbert, Thomas; Kawaoka, Yoshihiro; Feldmann, Heinz.

In: Journal of Infectious Diseases, Vol. 196, No. SUPPL. 2, 15.11.2007.

Research output: Contribution to journalArticle

Ebihara, H, Theriault, S, Neumann, G, Alimonti, JB, Geisbert, JB, Hensley, LE, Groseth, A, Jones, SM, Geisbert, T, Kawaoka, Y & Feldmann, H 2007, 'In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein', Journal of Infectious Diseases, vol. 196, no. SUPPL. 2. https://doi.org/10.1086/520590
Ebihara, Hideki ; Theriault, Steven ; Neumann, Gabriele ; Alimonti, Judie B. ; Geisbert, Joan B. ; Hensley, Lisa E. ; Groseth, Allison ; Jones, Steven M. ; Geisbert, Thomas ; Kawaoka, Yoshihiro ; Feldmann, Heinz. / In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. In: Journal of Infectious Diseases. 2007 ; Vol. 196, No. SUPPL. 2.
@article{999a9efc2b634208aa342ef00ab1007b,
title = "In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein",
abstract = "To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinant viruses expressing enhanced green fluorescent protein (eGFP) from additional transcription units inserted at different positions in the virus genome. These viruses showed in vitro phenotypes similar to that of wild-type ZEBOV (wt-ZEBOV) and were stable over multiple passages. Infection with one of the viruses expressing eGFP produced only mild disease in rhesus macaques, demonstrating a marked attenuation in this animal model. However, in mice lacking signal transducer and activator of transcription 1, both viruses expressing eGFP caused lethal cases of disease that were moderately attenuated, compared with that caused by wt-ZEBOV. In mice, viral replication could be easily tracked by the detection of eGFP-positive cells in tissues, by use of flow cytometry. These findings demonstrate that the incorporation of a foreign gene will attenuate ZEBOV in vivo but that these viruses still have potential for in vitro and in vivo research applications.",
author = "Hideki Ebihara and Steven Theriault and Gabriele Neumann and Alimonti, {Judie B.} and Geisbert, {Joan B.} and Hensley, {Lisa E.} and Allison Groseth and Jones, {Steven M.} and Thomas Geisbert and Yoshihiro Kawaoka and Heinz Feldmann",
year = "2007",
month = "11",
day = "15",
doi = "10.1086/520590",
language = "English (US)",
volume = "196",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "SUPPL. 2",

}

TY - JOUR

T1 - In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

AU - Ebihara, Hideki

AU - Theriault, Steven

AU - Neumann, Gabriele

AU - Alimonti, Judie B.

AU - Geisbert, Joan B.

AU - Hensley, Lisa E.

AU - Groseth, Allison

AU - Jones, Steven M.

AU - Geisbert, Thomas

AU - Kawaoka, Yoshihiro

AU - Feldmann, Heinz

PY - 2007/11/15

Y1 - 2007/11/15

N2 - To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinant viruses expressing enhanced green fluorescent protein (eGFP) from additional transcription units inserted at different positions in the virus genome. These viruses showed in vitro phenotypes similar to that of wild-type ZEBOV (wt-ZEBOV) and were stable over multiple passages. Infection with one of the viruses expressing eGFP produced only mild disease in rhesus macaques, demonstrating a marked attenuation in this animal model. However, in mice lacking signal transducer and activator of transcription 1, both viruses expressing eGFP caused lethal cases of disease that were moderately attenuated, compared with that caused by wt-ZEBOV. In mice, viral replication could be easily tracked by the detection of eGFP-positive cells in tissues, by use of flow cytometry. These findings demonstrate that the incorporation of a foreign gene will attenuate ZEBOV in vivo but that these viruses still have potential for in vitro and in vivo research applications.

AB - To facilitate an understanding of the molecular aspects of the pathogenesis of Zaire ebolavirus (ZEBOV) infection, we generated 2 different recombinant viruses expressing enhanced green fluorescent protein (eGFP) from additional transcription units inserted at different positions in the virus genome. These viruses showed in vitro phenotypes similar to that of wild-type ZEBOV (wt-ZEBOV) and were stable over multiple passages. Infection with one of the viruses expressing eGFP produced only mild disease in rhesus macaques, demonstrating a marked attenuation in this animal model. However, in mice lacking signal transducer and activator of transcription 1, both viruses expressing eGFP caused lethal cases of disease that were moderately attenuated, compared with that caused by wt-ZEBOV. In mice, viral replication could be easily tracked by the detection of eGFP-positive cells in tissues, by use of flow cytometry. These findings demonstrate that the incorporation of a foreign gene will attenuate ZEBOV in vivo but that these viruses still have potential for in vitro and in vivo research applications.

UR - http://www.scopus.com/inward/record.url?scp=38449123733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449123733&partnerID=8YFLogxK

U2 - 10.1086/520590

DO - 10.1086/520590

M3 - Article

VL - 196

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - SUPPL. 2

ER -